HomeStocksBETA

B

Beta Drugs

BETA Share Price

Healthcare

1,632.20

-39.20 (-2.35%)loss

as on 05 Dec 2025 at 15:29

1D

NSE

icon
icon
Bulb

Today Beta Drugs opened at 1,657.50 while its previous close was at 1,671.40. In todays trading session BETA reached a high of 1,661.40 and low of 1,601.10. The average traded price for today is 1,629.32. The 50 DMA stands at - and 200 DMA is at -. Looking at intraday trend, the stock is in Downtrend.

TradingView Logo

Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.

BETA Stock Performance

Markets Today

High

1,661.40

Low

1,601.10

Open at

1,657.50

Prev Close

1,671.40

Volumes

3,919

Avg Price

1,629.32

Lower Circuit

1,305.80

Upper Circuit

1,958.60

Last Traded Details

Quantity

1

Time

15:29:54

Price Movement

1,601.10
1,632.20
1,661.40
Loss 1.94%down side
up side1.76% profit

Historical Performance

3 M High

1,934.95

3 M Low

1,529.00

1 Yr High

2,300.00

1 Yr Low

1,501.00

3 Yr High

2,326.00

3 Yr Low

600.00

5 Yr High

2,326.00

5 Yr Low

104.80

1-Year Performance

1,501.00
1,632.20
2,300.00
loss1.94%down side
up side1.76% profit




BETA Fundamentals

View Fundamentals arrow

Company Valuation

Market Cap (₹ Cr.)

1,648

PE Ratio

38.90

PB Ratio

8.36

Dividend Yield

-

ROE

21.52%

ROCE

19.18%

Book Value (₹)

195.25

Face Value (₹)

10.00


Share Holding Pattern

Held ByDec 2024Mar 2025Jun 2025Sep 2025Nov 2025
Promoters
66.73%66.73%66.73%66.73%66.73%
Domestic Institutional Investors (DII)
0.00%0.00%0.00%0.00%0.00%
Foreign Institutional Investors (FII)
0.00%0.00%0.00%0.00%0.00%
Public Investors
21.60%21.81%21.75%21.81%21.78%
Government
0.00%0.00%0.00%0.00%0.00%

Promoters

Domestic Institutional Investors (DII)

Foreign Institutional Investors (FII)

Public Investors

Government


BETA Return Calculator

You have invested

Investment Period

Investment of ₹1,00,000 for 5 years would have become

0

Profit

-1,00,000 (1301.03%)


BETA Investment Returns

1 Week

1 Month

3 Months

6 Months

9 Months

SIP Logo

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.


BETA Technicals

View Technicals arrow

Moving Averages

PeriodSimpleSignal

Technical Indicators

IndicatorValueAction

Summary of Technical Indicators for BETA


Margin on BETA

Order TypeMargin to PayLeverageQuantityTrade ValueMargin AmountActions

*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).


BETA Financials Summary
No Data

Sorry, No Data Available at this Moment!


BETA Financials

View By:

Income Statement

In Crores

No Data

Sorry, No Data Available at this Moment!

Balance Sheet

In Crores

Yearly Balance SheetMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Share Capital1010101010
Reserve & Surplus5983113148187
Minority Interest00000
Non Current Liabilities16171312136
Current Liabilities33496385103
Total Liabilities118158198254436
Fixed Assets4055636589
Capital Work in Progress30000
Investments00000
Other Assets75103136190347
Total Assets118158198254436

Cash Flow

In Crores

Yearly Cash FlowMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Activities1930233136
Investing Activities-6-22-19-14-36
Financing Activities-8-1-3-8118
Net Cash Flow57210118

Corporate Actions

DateCorporate ActionInformation
6th Nov 2025, Thursday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q2 FY 25-26 Results
info
15th May 2025, Thursday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q4 FY 25-26 Results
info
26th Mar 2025, Wednesday
BONUSBonus
Bonus Ratio 1:20
6th Nov 2024, Wednesday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q2 FY 24-25 Results
info

The above dates are ex-dates.

View All Stock Events arrow

BETA Revenue Growth

All values are in Crores

Revenue

Profit

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2024-25226
11.43% profit
15
-29.65% Loss
FY 2023-24199
25.18% profit
22
16.58% profit
FY 2022-23159
26.45% profit
19
32.08% profit

Top Mutual Funds Invested in BETA


BETA Similar Stocks

View All arrow

Top Gainers Today

View All Gainers arrow

Top Losers Today

View All Losers arrow

NSE Indices Today

All NSE Indices arrow

BSE Indices Today

All BSE Indices arrow

Open IPOs

View All arrow


What's New In The Market

FAQs

Beta Drugs share price as of today is ₹ 1,632.20 as on 05 Dec 2025 at 15:29.
The 52W high of Beta Drugs is ₹ 2,300.00 and 52W low is ₹ 1,501.00 as of 05 Dec 2025 at 15:29.
The past returns of Beta Drugs share are -
  • Past 1 year: -27.22%
  • Past 3 years: 123.74%
  • Past 5 years: 1,301.03%
The PE and PB ratio of Beta Drugs stands at 38.90 and 8.36 respectively as on 05 Dec 2025 at 15:29.
The EPS of Beta Drugs is 0.00 for the quarter ended 0.00 and 42.02 for the financial year 2024-25.
The shareholding pattern of Beta Drugs is as follows:
  • DIIs - 0.00%
  • FII - 0.00%
  • Promoters - 66.73%
  • Public Investors 21.78%
  • Goverenment - 0.00%
Yes, you can buy shares of Beta Drugs online by opening Demat account with Dhan.
If you are a Dhan user already, you can buy Beta Drugs stocks from Dhan Trading App or Web Trading Platform. If you are new to Dhan follow the below steps:
  1. Download the Dhan App to Open a Demat Account
  2. Navigate to the “Money Tab”
  3. Add money to your account
  4. Search for Beta Drugs share
  5. Tap on “Buy”
With Dhan you can start a daily, weekly or monthly SIP in Beta Drugs.
You can easily buy the shares of Beta Drugs even after the markets are closed using the After Market Order feature on Dhan Trading App.
Candle bars with Screen
Invest in BETA
Candle bars with Screen

Pay Zero Brokerage on Delivery

Candle bars with Screen

Open FREE Demat Account

Indian Flag

+91

Or Scan the QR Code to download the Dhan App

QR code Logo


Invest & Trade with a Trading
Platform That's icon

Open your Dhan Account in minutes!


border

Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2025 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered & Corporate Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104, Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. Issued in the interest of the investors.


Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | Investor Charter for Research Analyst | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Grievances RA | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors